Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 08/01/19
End: 07/01/21
Due: 07/01/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir | NCT02104700 | Philip Grant | user2@example.com | None | 2014-04-30 | 2016-07-31 | 2017-07-31 | - | - | 2025-07-14 |
| Effect of Reducing Nucleotide Exposure on Bone Health (ReNew) | NCT03549689 | Philip Grant | user2@example.com | None | 2019-08-01 | 2021-07-01 | 2022-07-01 | - | - | 2025-07-14 |